Hypera S.A. operates as a pharmaceutical company in Brazil. The company offers prescription medications under the Farmasa, Neo Química, and Luper brands; and over-the-counter medications comprising laxative, antacid, antispasmodic, topical antiseptic, topical, nasal decongestant, and other drugs under Gelol, Anapyon, Biotônico Fontoura, Epocler, Merthiolate, Tamarine, and Rinosoro brands. It also provides similars and generics under the Neo Química brand; dermocosmetics under the Lanidrant, Agecare, Dersab, Epidac, Epidrat, Episol, Hidramamy, Creme rejuvenecedor, Blancy, and Pielus brands; and food supplements and sweeteners. The company was formerly known as Hypermarcas S.A. and changed its name to Hypera S.A. in February 2018. The company was founded in 2001 and is headquartered in São Paulo, Brazil.
Industry, Sector and Symbol
Stock Exchange OTCMKTS
Industry Toilet preparations
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:HYPMY
Previous Symbol
CUSIPN/A
Phone55-80-0771-7017
Debt
Debt-to-Equity Ratio0.04
Current Ratio3.40
Quick Ratio2.91
Price-To-Earnings
Trailing P/E Ratio18.22
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual Sales$538.51 million
Price / Sales9.28
Cash Flow$0.2874 per share
Price / Cash Flow27.49
Book Value$3.83 per share
Price / Book2.06
Profitability
EPS (Most Recent Fiscal Year)N/A
Net Income$302.21 million
Net Margins31.62%
Return on Equity13.69%
Return on Assets10.97%
Miscellaneous
EmployeesN/A
Outstanding Shares632,240,000
Market Cap$5.18 billion
OptionableNot Optionable
HYPERA S A/S (OTCMKTS:HYPMY) Frequently Asked Questions
What is HYPERA S A/S's stock symbol?
HYPERA S A/S trades on the OTCMKTS under the ticker symbol "HYPMY."
When is HYPERA S A/S's next earnings date?
Has HYPERA S A/S been receiving favorable news coverage?
Press coverage about HYPMY stock has trended somewhat positive on Saturday, according to InfoTrie Sentiment. The research group rates the sentiment of news coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. HYPERA S A/S earned a news sentiment score of 0.7 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 2.0 out of 10, meaning that recent news coverage is very unlikely to have an impact on the company's share price in the near term.
Who are some of HYPERA S A/S's key competitors?
Who are HYPERA S A/S's key executives?
HYPERA S A/S's management team includes the folowing people:
- Mr. Breno Toledo Pires de Oliveira, Chief Exec. Officer
- Ms. Vivian Angiolucci, Chief Financial Officer
- Mr. Carlos Roberto Scorsi, Chief Operating officer (Age 56)
- Juliana Aguinaga Damião Salem, Chief Legal & Compliance Officer
- Mr. Nelson José de Mello, Chief Corp. Relations Officer (Age 59)
How do I buy shares of HYPERA S A/S?
Shares of HYPMY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is HYPERA S A/S's stock price today?
One share of HYPMY stock can currently be purchased for approximately $7.90.
How big of a company is HYPERA S A/S?
HYPERA S A/S has a market capitalization of $5.18 billion and generates $538.51 million in revenue each year.
What is HYPERA S A/S's official website?
How can I contact HYPERA S A/S?
HYPERA S A/S's mailing address is Av. Magalhaes de Castro 4800 - 24¿ andar Edificio Continental Tower, Sao Paulo D5, 05502. The company can be reached via phone at 55-80-0771-7017 or via email at [email protected]
MarketBeat Community Rating for HYPERA S A/S (OTCMKTS HYPMY)
MarketBeat's community ratings are surveys of what our community members think about HYPERA S A/S and other stocks. Vote "Outperform" if you believe HYPMY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HYPMY will underperform the S&P 500 over the long term. You may vote once every thirty days.
